Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 11

Results For "EIC"

135 News Found

Philips Capsule surveillance receives USFDA clearance
Digitisation | March 16, 2022

Philips Capsule surveillance receives USFDA clearance

Clinical surveillance solution is designed to identify emergent patient deterioration and offer enhanced patient data visibility, flexible viewing options, and clinical decision support


Evonik expands production of plant-derived cholesterol in Germany
News | March 06, 2022

Evonik expands production of plant-derived cholesterol in Germany

The large-scale production of PhytoChol in Hanau, Germany, will meet an increased market demand for cholesterol


DiscGenics presents positive Phase1/2 study of Cell therapy for degenerative disc disease
Biotech | February 27, 2022

DiscGenics presents positive Phase1/2 study of Cell therapy for degenerative disc disease

Allogeneic discogenic cell therapy was well tolerated and produced clinically meaningful, statistically significant improvements in low back pain, function, and quality of life by 12 weeks following intradiscal injection


Solvay invests in Zurich-based 3D printing startup
Startup | February 22, 2022

Solvay invests in Zurich-based 3D printing startup

9T Labs provides a cost-competitive solution for manufacturing that will allow structural CFRP parts to replace metals at a much faster rate in demanding applications in many sectors such as aerospace, automotive and healthcare


IIT Delhi develops strategy for development of drug molecules
Biotech | February 21, 2022

IIT Delhi develops strategy for development of drug molecules

The researchers are of the view that the new drug designing strategy demonstrated by them could also be adopted to treat retroviral infections.


Gamida Cell initiates rolling submission of Biologics License Application for Omidubicel
Biotech | February 10, 2022

Gamida Cell initiates rolling submission of Biologics License Application for Omidubicel

On track to complete the BLA submission in the first half of 2022


Daiichi Sankyo commences trial for booster mRNA vaccine against Covid-19
Biotech | January 31, 2022

Daiichi Sankyo commences trial for booster mRNA vaccine against Covid-19

DS-5670 is an mRNA vaccine against Covid-19 using a novel nucleic acid delivery technology discovered by the company


DCGI approves Phase 3 clinical trial of Stempeucel to treat Covid-19 patients
Biotech | January 18, 2022

DCGI approves Phase 3 clinical trial of Stempeucel to treat Covid-19 patients

The drug is aimed at treating Covid-19 patients with Acute Respiratory Distress Syndrome (ARDS)


Lilly and Entos  collaborate for therapies in multiple neurologic indications
Biotech | January 07, 2022

Lilly and Entos collaborate for therapies in multiple neurologic indications

Entos will receive an initial payment of US $50 million, which includes an equity investment by Lilly


Kyverna Therapeutics announces licence agreement with NIH
Biotech | January 04, 2022

Kyverna Therapeutics announces licence agreement with NIH

This next-generation CAR T construct was designed to improve the tolerability profile of conventional CD19 CAR Ts and developed in the laboratory of James N. Kochenderfer, M.D., at the National Cancer Institute, part of the NIH, the same laboratory that discovered axicabtagene ciloleucel